Prevalence of Attention Deficit Hyperactive Disorder (ADHD) and stimulant prescribing rates are on the rise in the United States. Similarly, there has been a significant increase in the prevalence of Stimulant Use Disorders (StUD) and stimulant-associated overdose deaths. While there are no FDA approved medications for the treatment of StUD, the American Society of Addiction Medicine (ASAM) in conjunction with the American Academy of Addiction Psychiatry (AAAP) recently published a Clinical Practice Guideline on the Management of Stimulant Use Disorder, that includes recommendations for the concurrent management of ADHD and StUD. This presentation will explore the complexities of making the diagnosis of ADHD in adults and review the available evidence for treatment of Stimulant Use Disorders comorbid with ADHD.

Learning Objectives

• Increase awareness for the complexity involved in accurately diagnosing Attention-Deficit / Hyperactivity Disorder (ADHD) in adults
• Discuss the evidence for stimulant treatment of adult ADHD alone, and when comorbid with a Substance Use Disorder (SUD)
• Discuss the evidence for SUD alone, and when comorbid with ADHD